Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.15 USD | +1.90% | +9.41% | -55.94% |
May. 15 | Piper Sandler Cuts Akoya Biosciences Price Target to $6 From $8, Maintains Overweight Rating | MT |
May. 14 | Top Midday Decliners | MT |
Financials (USD)
Sales 2024 * | 105M | Sales 2025 * | 131M | Capitalization | 106M |
---|---|---|---|---|---|
Net income 2024 * | -51M | Net income 2025 * | -32M | EV / Sales 2024 * | 1.1 x |
Net Debt 2024 * | 8.75M | Net cash position 2025 * | 7.29M | EV / Sales 2025 * | 0.76 x |
P/E ratio 2024 * |
-1.96
x | P/E ratio 2025 * |
-3.56
x | Employees | 330 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 52.84% |
Latest transcript on Akoya Biosciences, Inc.
1 day | +1.90% | ||
1 week | +9.41% | ||
1 month | -43.72% | ||
3 months | -62.54% | ||
6 months | -51.03% | ||
Current year | -55.94% |
Managers | Title | Age | Since |
---|---|---|---|
Brian McKelligon
CEO | Chief Executive Officer | 55 | 17-06-30 |
Johnny Ek
DFI | Director of Finance/CFO | 49 | 23-03-19 |
Pascal Bamford
CTO | Chief Tech/Sci/R&D Officer | - | 21-10-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Shepler
CHM | Chairman | 67 | 15-10-31 |
Myla Lai-Goldman
BRD | Director/Board Member | 66 | 21-09-15 |
Director/Board Member | 67 | 19-08-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.00% | 1,487 M€ | +7.77% | - | |
0.00% | 9 M€ | +9.86% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 2.15 | +1.90% | 198,857 |
24-05-30 | 2.11 | -6.64% | 247,788 |
24-05-29 | 2.26 | -1.74% | 653,048 |
24-05-28 | 2.3 | +17.05% | 1,164,588 |
24-05-24 | 1.965 | +1.29% | 449,239 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-55.94% | 106M | |
+7.01% | 217B | |
+11.01% | 190B | |
+19.20% | 143B | |
+30.79% | 111B | |
+1.48% | 64.59B | |
+13.95% | 52.36B | |
-0.16% | 48.45B | |
-6.20% | 38.03B | |
+0.91% | 35.61B |
- Stock Market
- Equities
- AKYA Stock